StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Monday. The firm issued a hold rating on the stock.
China Pharma Stock Performance
NYSE:CPHI opened at $0.17 on Monday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.69. The company has a 50 day simple moving average of $0.21 and a two-hundred day simple moving average of $0.22.
About China Pharma
Recommended Stories
- Five stocks we like better than China Pharma
- The 3 Best Blue-Chip Stocks to Buy Now
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Investing in Commodities: What Are They? How to Invest in Them
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
